瑞密斯医药是匈牙利吉瑞大药厂与瑞密斯医药共同在华成立的、由匈牙利吉瑞大药厂持有多数股权的合资企业。合资企业设立后，瑞密斯/吉瑞密斯将进一步推动匈牙利吉瑞大药厂处方药和非处方药产品在中国市场的销售，并致力于引进第三方产品。2013年，瑞密斯/吉瑞密斯实际员工数已达300名，实现销售额达4亿人民币。在中国，瑞密斯是仅有几家拥有自身销售团队及品牌销售权，且能同时为处方药和非处方药产品提供综合性服务的企业之一。作为一家全新的、职能一体化的医药公司，瑞密斯遵照跨国企业运营标准，为您的产品在中国市场的成功销售提供所有必需的综合性服务。
更多信息请浏览企业网址：www.rxmidas.com

Rxmidas is a majority stake JV of Gedeon Richter with Rxmidas Pharmaceuticals in China. Rxmidas/GRmidas will further boost the expansion of Gedeon Richter’s Rx and OTC products and licensed-in third party products in China. Rxmidas/GRmidas achieved sales of 55 mio USD in 2012 with a staff of 270. Rxmidas/GRmidas is one of the only service providers in China who can cover both the Rx and OTC market with their own sales-force and integrated services under the Rxmidas and GRmidas brand franchises. Rxmidas/GRmidas is a new breed of service provider being a fully integrated pharmaceutical company, operating according to multinational standards and offering in house all services necessary for your products to be successful in China.
Please visit the enterprise website to get more information: www.rxmidas.com